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Abstract
Genome wide association studies (GWAS) in obesity have identified a large number of noncoding 
loci located near genes expressed in the central nervous system. However, due to the difficulties in 
isolating and characterizing specific neuronal subpopulations, few obesity-associated SNPs have 
been functionally characterized. Leptin responsive neurons in the hypothalamus are essential in 
controlling energy homeostasis and body weight. Here, we combine FACS-sorting of leptin-
responsive hypothalamic neuron nuclei with genomic and epigenomic approaches (RNA-seq, 
ChIP-seq, ATAC-seq) to generate a comprehensive map of leptin-response specific regulatory 
elements, several of which overlap obesity-associated GWAS variants. We demonstrate the 
usefulness of our leptin-response neuron regulome, by functionally characterizing a novel 
enhancer near Socs3, a leptin response-associated transcription factor. We envision our data to 
serve as a useful resource and a blueprint for functionally characterizing obesity-associated SNPs 
in the hypothalamus.
Introduction
Obesity dramatically increases the risk of morbidity from hypertension, dyslipidaemia, 
diabetes and cardiovascular diseases and is a major public health concern1-3. Both 
environmental and genetic factors are involved in the onset and progression of weight gain4, 
with genetic factors being the major component5-7. By building on major advances in the 
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description of molecular pathways implicated in food intake regulation and the control of 
body weight in mice, a number of rare obesity causing protein-coding variants have been 
identified in humans8. Most of the genes implicated in these monogenic forms of obesity 
encode proteins of the leptin axis and brain expressed targets of leptin in the 
hypothalamus9,10.
In parallel to monogenic causes of obesity, genome-wide association studies (GWAS) have 
identified over 250 loci for body mass index (BMI)10. Most of these GWAS loci represent 
clusters of common SNPs in noncoding regions11 that likely alter gene expression and have 
been found to reside primarily near genes involved in central nervous system (CNS)-related 
processes12. As the associated noncoding variant/s are not necessarily the causative 
variant/s, pinpointing the relationship between variants and causal regulatory elements and 
their target genes remains challenging. Gene regulatory maps, such as those generated by the 
ENCODE project, can allow the detection of potentially causative sequences nearby GWAS 
hits13-15. However, as gene regulatory elements, such as enhancers, tend to be cell type-
specific16 and the hypothalamus contains a complex set of neuronal subtypes, the ability to 
identify obesity-associated regulatory elements remains highly constrained.
Here, we demonstrate the feasibility of establishing a comprehensive map of activated DNA 
regions in a sub-population of hypothalamic neurons by focusing on first order leptin-
responsive neurons. We show that this map is consistent with the transcriptional activity of 
these neurons, leads to identification of relevant enhancers and provides a physical blueprint 
for identifying and testing the relevance of human obesity associated SNPs uncovered by 
GWAS.
Results
Nuclei isolation from leptin-responsive neurons
The hypothalamus is a complex brain structure composed of neuronal and non-neuronal 
cells such as astrocytes, microglia, oligodendrocyte and endothelial cells17. This complexity 
also makes separating these cells from one another for subsequent genomic analyses 
extremely complex. To map the genes and regulatory elements that are active in leptin-
responsive neurons, a subset of hypothalamic neurons that includes Pomc, Agrp/Npy 
neurons, we generated mice in which the nuclei of these cells was fluorescently labeled and 
used these nuclei for subsequent cell isolation. Specifically, we crossed Leprbcre mice that 
carry an internal ribosome entry site (IRES) followed by CRE recombinase downstream of 
exon 18b of the Lepr gene18, with mice that express, in a Cre dependent manner, the SUN1 
nuclear membrane protein fused to GFP19 (Fig. 1a). We confirmed that GFP labelling was 
restricted to the nucleus of subpopulation of neurons in the Arcuate (ARC), dorso- (DMH) 
and ventromedial hypothalamus (VMH), recapitulating endogenous Leprb expression 
pattern (Fig. 1b). We then established a protocol to isolate the cell nuclei from dissected 
hypothalamus (see Methods). This was followed by FACS sorting to separate the GFP 
positive from the GFP negative nuclei (Fig. 1c, Supplementary Figure 1). As the nutritional 
and/or the leptin-activation status may affect the transcriptome or regulome of these neurons, 
we performed the nuclear isolation under different conditions. Groups of mice were either 
fed, fasted or (to isolate the specific effect of leptin) given leptin injections chronically or 
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acutely during fasting and experiments were carried out at the same time points during the 
day (Fig. 1d). For each condition, nuclei isolations were done from hypothalamus pooled 
from both male and female (to account for sex-specific differences) adult mice (2–4 months 
old) (Supplementary Table 1). For each assay, at least 5 mice per RNA-seq or ATAC-seq and 
at least 20 mice for ChIP-seq with three biological replicates for RNA-seq (total of 60 mice) 
and two for ATAC-seq (total of 40 mice) and ChIP-seq (total of 160 mice) were used.
Nuclear transcriptome of leptin-responsive neurons
In order to validate enrichment for Leprb expressing neuron nuclei, prior to mapping 
regulatory elements by H3K27ac ChIP-seq and ATAC-seq, and to provide a solid basis for 
matching the transcriptional status with the gene regulatory status in nuclei from leptin-
responsive neurons, we analyzed the transcriptome of the sorted nuclei obtained by our 
method. We performed RNA-seq both on GFP-positive and GFP-negative sorted nuclei in all 
physiological conditions tested. The specificity of our nuclei isolation protocol was validated 
by the high level of enrichment of LepR and by the strong depletion of genes specifically 
expressed in oligodendrocytes (Mag), microglia (Cx3cr1) and astrocytes (Aldh1l1) (Fig. 2a). 
Comparison of our isolated GFP positive nuclei population versus all other cell types (GFP 
negative) found 1,897 genes to be significantly enriched in this population with Lepr being 
the most differentially expressed gene (Fig. 2b). Gene ontology analysis for genes that are 
differentially expressed in GFP-positive sorted nuclei showed enrichment for genes that 
function in energy homeostasis, such as eating behavior and regulation of appetite 
(Supplementary Figure 2a). Weighted correlation network analysis (WGCNA20), an 
unsupervised method to identify modules of co-expressed genes, found 10 modules to be 
highly correlated with GFP-positive and GFP-negative cell states (Supplementary Figure 
3a). Gene ontology analysis of two of the most significantly correlated modules, ME3 and 
ME6, showed an enrichment for genes involved in neuronal activity for ME3 and a variety 
of terms for ME6 (Supplementary Figure 3b).
In addition to a global analysis, we also looked at individual genes. We detected significantly 
higher levels of expression in GFP-positive sorted nuclei of other leptin pathway associated 
genes such as Stat3 (Fig. 2b, Supplementary data file 1). In addition, we observed that the 
growth hormone receptor (Ghr) gene, that was recently reported to be co-expressed with 
Lepr in the hypothalamus and plays an important role in glucose metabolism21, is also 
significantly enriched in the leptin responsive transcriptome.
While the difficulty of isolating whole neurons from adult mice has restricted the capacity to 
perform transcriptome analysis on neuronal sub-populations, Translating Ribosome Affinity 
Purification (TRAP), a method in which genetically labeled ribosomes can be 
immunoprecipitated from neuronal homogenates, has recently allowed the identification of 
translated transcripts (translatome) from specific neurons, including leptin-responsive 
neurons22,23. Comparison of our results to the previously published TRAP-seq dataset that 
analyzed the LepRb-neuron transcriptome22, found 88 upregulated (37.4%) and 175 
downregulated (65.8%) genes that also showed up and down regulation in LepRb positive 
and LepRb negative cells in our dataset (Supplementary Figure 4a). In addition, recent work 
using TRAP-seq has implicated activating transcription factor 3 (Atf3) to be increased in 
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LepRb neurons and function as a mediator of leptin signaling23. Analyses of our data also 
shows Atf3 to be upregulated in LepRb neurons (Supplementary Figure 4b). Importantly, 
unlike translatome analysis, nuclear transcriptomes also allows for the analysis of non-
translated RNA species. We therefore analyzed our RNA-seq dataset for long noncoding 
RNAs (lncRNAs) that are differentially expressed compared to all other cell types (GFP 
negative). We found numerous unique and 79 differentially expressed lncRNAs (33 
increased and 46 decreased) (Fig. 2c, Supplementary data file 1).
To identify genes that specifically respond to physiological changes in leptin-responsive 
neurons, we compared their nuclear transcriptome under different physiological conditions. 
Analyses of all conditions for our GFP-positive nuclei, found 1,257 genes to be upregulated 
by leptin and 853 to be downregulated when comparing fasted mice to ones injected every 
12 hours (Fig. 3a). Gene ontology analyses found enrichment for genes associated with 
neuronal function (Supplementary Figure 2b). As expected, we found that the expression of 
Socs3, a known leptin responsive transcriptional target24, was decreased by fasting and 
rapidly induced by leptin (Fig. 3b). Interestingly, the most differentially expressed gene 
following leptin treatment was ETS variant 6 (Etv6) (Fig. 3b). Similar to Socs3, Etv6 is also 
a known transcriptional target of Stat3 and is known to inhibit its function in tumor cells25, 
but has yet to be associated with leptin response. Another leptin response gene was 
guanylate cyclase 2C (Gucy2c) (Fig. 3b). Gucy2c encodes a transmembrane receptor that is 
expressed in the hypothalamus and causes obesity with an increase in leptin serum levels 
when deleted in mice26. Combined, our results show that transcriptional analysis of FACS 
sorted nuclei can be used to detect transcriptional changes in small neuronal subpopulations 
under different physiological conditions.
Mapping gene regulatory regions in neuronal subpopulations
To identify gene regulatory elements that are active in LepRb expressing neurons, we 
performed ATAC-seq and ChIP-seq for H3K27ac in sorted nuclei from these neurons. While 
the starting material for ATAC-seq are nuclei, making the procedure straightforward, ChIP-
seq required the development of a novel protocol following nuclei sorting. Briefly, nuclei 
were first sorted and then isolated via centrifugation in 1M CaCl2 and 1M MgAc2. Gentle 
fixation using 1% formaldehyde followed by quenching with 125 mM glycine was carried 
out on the pellet which was subsequently lysed and subjected to ChIP (see Methods for more 
details).
We identified a total of 32,377 regions that are active in leptin responsive neurons by ATAC-
seq and 50,218 regions that are active by H3K27ac ChIP-seq respectively. To confirm the 
relevance and specificity of the identified elements, we compared our RNA-seq to our ChIP-
seq and ATAC-seq results and found that active regulatory regions correlated to levels of 
gene transcription. Genes near an ATAC-seq or ChIP-seq LepRb enriched peak in leptin 
responsive neurons were significantly more likely to show the same direction of gene 
expression changes when compared to peaks with non-significant differences between GFP 
positive or negative neurons (p-value < 9.3e-7 or 2.2e-16 for ATAC-seq and ChIP-seq 
respectively; Wilcoxon rank sum test) (Supplementary Figure 5). We further examined 
known leptin pathway associated genes and compared the active regions for these genes in 
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leptin-responsive neurons (from GFP+ nuclei after sorting) to those from all the other 
hypothalamic cell types (GFP- nuclei after sorting). As specific examples, we observed a 
strong enrichment of H3K27ac ChIP-seq and ATAC-seq signals specifically in GFP-positive 
nuclei near the Lepr gene promoter, the top positively differentially expressed gene in our 
RNA-seq compared to all other cell types (Fig. 2b) and a reduction near the Sim1 promoter 
(Fig. 4a-b), one of the top negatively differentially expressed gene (Fig. 2b).
We then compared peak enrichment between LepRb GFP positive nuclei and all other 
hypothalamic cell types (GFP negative). We found 17,629 H3K27ac ChIP-seq peaks to be 
differentially enriched (Supplementary data file 2), with 9,903 H3K27ac peaks upregulated 
in GFP positive nuclei and 7,726 downregulated (Fig. 4c-d, Supplementary data file 2). To 
validate that we are obtaining ChIP-seq peaks that are unique to LepRb GFP positive nuclei, 
we next used the Genomic Regions Enrichment of Annotations Tool [GREAT27]. This tool 
analyzes the nearby genes of a set of genomic regions and provides biological annotations 
that are enriched for these genes. Analysis of our H3K27ac upregulated peaks found that the 
top enriched term for mouse phenotype for the neighboring genes was ‘increased total body 
fat amount’ (Fig. 4e), supporting that we are obtaining a relevant enriched set of genomic 
peaks.
We next analyzed peaks for transcription factor binding sites (TFBS) enrichment. Using 
MEME-ChIP28 on H3K27ac peaks differentially enriched peaks between GFP-positive and 
GFP-negative nuclei identified multiple known and novel motifs differentially represented 
between these two datasets. In the GFP-positive enriched peak set, the STAT4 (MA0518.1) 
motif was the most overrepresented, with an e-value of 9.1e−470 occurring 63,939 times 
(Supplementary Table 2). Another sixteen motifs, including CDX2, NEUROD1, 
MAX:MYC, SMAD2/¾, were identified as overrepresented in GFP-positive enriched peaks, 
but not in GFP-negative enriched peaks. The most highly enriched known motif in the GFP-
negative enriched peaks was KLF5 (MA0599.1; e-value 6.7e−172; Supplementary Table 2). 
Another seventeen motifs, including CREB3L1, SOX8 and ELK4, were identified as 
overrepresented in the GFP-negative enriched peaks, but not in the GFP-positive enriched 
peaks. We also analyzed our data for H3K27ac ChIP-seq or ATAC-seq peaks that are 
enriched following leptin response [i.e. comparing between chronic leptin injections (LLL) 
and saline injections (SSS)]. We found 146 H3K27ac ChIP-seq and 28 ATAC-seq peaks to 
be enriched (raw p-value of 0.01; Wald test) between these two conditions (Supplementary 
data file 2).
Functional characterization of a Socs3 enhancer
To further validate whether our LepRb neuron nuclei regulome contains relevant regulatory 
regions, we set out to test candidate enhancer sequences for their function. We selected three 
candidate enhancers located downstream of Socs3 (Socs3–1, Socs3–2, and Socs3–3). These 
regions were chosen due to their increased enrichment of H3K27ac marks and chromatin 
accessibility in nuclei of LepRb expressing neurons (Fig. 5a). We tested the ability of these 
enhancers to increase the activity of a minimal promoter driving the expression of luciferase 
in mHypoA-Pomc cells, an established cell line from mouse hypothalamus Pomc-expressing 
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neurons29. From the three sequences, one sequence, Socs3–3, showed significant enhancer 
activity in this cell type (Fig. 5b).
To test whether Socs3–3 regulates Socs3 expression, we used CRISPR inactivation 
[CRISPRi30] to target this sequence and then measured endogenous Socs3 expression levels. 
Using lentivirus, two different sgRNAs targeting the Socs3–3 enhancer were infected into 
mHypoA-Pomc cells along with a catalytic inactive Cas9 (dCas9) fused to the KRAB 
repressor. We found that Socs3 expression was significantly decreased by either sgRNA 
(Fig. 5c). A similar analysis of the neighboring genes around Socs3, 
phosphatidylglycerophosphate synthase 1 (Pgs1) and threonine aldolase 1(Tha1), did not 
find any significant change in their expression (Fig. 5d-e). Combined, our results confirm 
that our approach can be used to identify functionally relevant regulatory regions in sub-
populations of neurons.
LepRb neuron regulatory elements overlap obesity-associated SNPs
We next set out to test whether obesity-associated GWAS SNPs could be physically linked 
to regulatory elements identified in LepRb neurons. We obtained a list of GWAS reported 
obesity-associated single nucleotide polymorphisms (SNPs) from Ghosh et al12 and used 
Plink31 to obtain a list of all SNPs that are in linkage disequilibrium with these tag SNPs 
using an r2 of at least 0.8 as a cutoff (Supplementary Table 3). The coordinates of our 
H3K27ac and ATAC peaks were transferred to the human genome (hg19) using the UCSC 
LiftOver tool (see Methods). Out of the 61,180 merged peaks, 51,983 (85%) peaks 
successfully lifted over to hg19. We then tested whether the H3K27ac ChIP-seq or ATAC-
seq peaks that were found in LepRb GFP-positive nuclei overlap our list of obesity-
associated SNPs. For H3K27ac peaks, we found 196 GFP-positive peaks that overlap 
obesity-associated SNPs, an observation that was statistically significant (p-value <= 1e−4) 
by a random permutation test carried out by shuffling peak locations 1e4 times and 
excluding ENCODE blacklist regions32. Similarly, for ATAC-seq peaks, we found 56 GFP-
positive peaks that overlap obesity-associated SNPs. We next compared our H3K27ac peaks 
to mouse ENCODE peaks after converting them using the UCSC LiftOver tool to human 
genome (hg19). While many tissue types showed similar enrichment ratios and p-values to 
the GFP positive dataset, the SNPs and genomic regions of the H3K27ac peaks were distinct 
across groups (Figure 6a). We observed similar results for our ATAC-seq peaks (p-value 
equal to 3.2e−3). Other ATAC-seq datasets19 in vasoactive intestinal peptide expressing 
interneurons (VIP), parvalbumin expressing fast-spiking interneurons (PV) and excitatory 
pyramidal neurons did not show as significant of an enrichment by this method (p-value 
equal to 0.012, 0.055, and 0.125, respectively). In summary, our analyses show a unique 
significant enrichment for obesity-associated SNPs in our predicted regulatory elements.
We also examined a number of specific GWAS loci to determine whether the Leprb 
regulome could help identify obesity-associated functional SNPs. For example, the Lepr 
locus (Fig. 4a), where SNPs were found to be associated with obesity33, showed an overlap 
between these SNPs and LepRb regulatory elements. Other examples include the SEC16 
homolog B, endoplasmic reticulum export factor (SEC16B), SH2B adaptor protein 1 
(SH2B1), gastric inhibitory polypeptide receptor (GIPR) and TNNI3 interacting kinase 
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(TNNI3K) loci (Fig. 6b-c; Supplementary Figure 6), all of which have been highly 
associated with obesity through GWAS11.
We also tested whether our LepRb neurons overlap hypothalamus expression quantitative 
loci (eQTLs) as determined by the Genotype-Tissue Expression (GTEx) project34. We found 
a significant enrichment (<1e−3 p-value; random permutation test for 1000 data shuffles 
excluding ENCODE black list regions32) for eQTLs in both our H3K27ac ChIP-seq and 
ATAC-seq peaks (Supplementary data file 3). These results show that our characterized 
LepRb neuron nuclei regulatory elements can be used as a blueprint to identify putative 
functional obesity-associated variants.
Discussion
Numerous GWASs have been performed to find common genetic variants associated with 
obesity, and over 250 loci have been identified in which clusters of linked SNPs predispose 
to an increase in BMI10. However, little progress has been made in outlining the causal 
SNPs and understanding the mechanisms by which they affect the phenotype. Most of these 
SNPs are found in noncoding regions of the genome and maps of relevant functional 
elements potentially affected by these SNPs are required. In particular, since obesity-
associated loci appear to be most often located near genes expressed in the central nervous 
system, the capacity to map genomic regulatory regions in sub-populations of neurons 
implicated in the control of energy homeostasis would be a first step towards linking obesity 
associated SNPs with their function.
Here, using LepRb expressing neurons as an example, we developed a unique protocol that 
can identify gene regulatory elements from a relevant sub-population of neurons thus 
providing a resource to start addressing the functional consequences of human obesity-
associated SNPs. First, we demonstrate that FACS sorting of a genetically labeled sub-
population of hypothalamic neurons results in a highly enriched nuclei population. This 
method is dependent on the expression of a nuclei anchored GFP in the relevant population 
of neurons and could therefore be used for any neuronal population for which a Cre reporter 
is available.
The characterized LepRb expressing neuron population is still heterogeneous and is from 
both genders (does not account for sex-specific differences). More specific sub-populations 
of Cre expressing neurons could be isolated by nuclei labeling through stereotaxic injection 
of a Cre dependent (DIO) Adeno Associated Virus (AAV) expressing SUN1 sfGFP. For 
example, this method could be used to find regulatory regions in LepRb expressing neurons 
that are more specific to the arcuate nucleus or the dorsomedial hypothalamic nucleus. This 
approach also provides the opportunity of labelling the nuclei that are expressing Cre only at 
the time of injection. Finally, if a Cre reporter is not available, stereotaxic injection of AAVs 
expressing Cre recombinase under the control of a synapsin promoter, that confers gene 
expression in neurons, can also be used to label anatomical subsets of neuronal nucleis in 
R26-CAG-LSL-Sun1-sfGFP-myc mice. We also developed a unique protocol that provides 
the ability to carry out ChIP-seq for H3K27ac on these sorted nuclei. We demonstrate the 
fidelity of this map to transcriptional activity and its functional relevance. We did not 
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however identify many leptin treatment enriched peaks. This is likely due to technical and 
statistical constraints, using an extremely low number of nuclei in these assays 
(Supplementary Table 1) leading to our inability to generate statistically significant 
comparisons. Further development of this protocol could allow increased sensitivity and 
generalization to the study of additional histone marks or more specific transcription factors.
Demonstrating that our map will be useful for linking genotype with an obesity phenotype, 
we highlight the overlap between our LepRb neurons H3K27ac peaks and GWAS SNPs at a 
subset of obesity-associated loci, including some with strong BMI associations. Our 
characterized regulatory elements provide candidate sequences for further functional 
analyses of these obesity-associated loci. Of note and as expected, several obesity GWAS 
peaks did not overlap our LepRb neuron regulatory elements, underlying the necessity to 
establish regulatory maps of other hypothalamic neuronal populations implicated in body 
weight regulation such as MC4R expressing neurons. The two-pronged approach we 
describe to demonstrate the functional relevance of identified SOCS3 enhancers can also be 
further adapted to the study of the functional effects of candidate obesity-associated SNPs 
on regulatory function. Finally, we also provide evidence that nuclear transcriptomes that 
can be obtained following nuclei sorting are highly specific, can be used to study the effect 
of physiological changes on transcriptional activity in specific neuronal populations, and 
unlike TRAP-seq allow for the study of untranslated RNA.
Methods
Mice
LepRbcre (Leprtm3(cre)Mgmj)18 heterozygote mice were crossed to SUN1-sfGFP 
(Gt(ROSA)26Sortm5(CAG-Sun1/sfGFP)Nat)19 homozygote mice, both on a mixed 129S1/Sv and 
C57BL/6J background, to generate LepRcre/+; SUN1-sfGFP/+ mice. Mice were genotyped 
by PCR using primer sequences described in Supplementary Table 4. Mice were fed ad 
libitum Picolab mouse diet 20, 5058 containing 20% protein, 9% fat, 4% fiber for whole 
study. Calories provided by: protein 23.210%, fat (ether extract) 21.559% and carbohydrates 
55.231%. LepRcre/+; SUN1-sfGFP/+ mice between 2–4 months old were then randomly 
chosen (see Supplementary Table 1 for number of mice and genders used) for the following 
treatments: 1) Fed ad libitum for 36 hours; 2) Fasted for 36 hours and injected with saline 
three times (12, 24, and 34 hours after the beginning of fasting); 3) Fasted for 36 hours and 
injected with leptin (5 mg/kg body weight) three times (12, 24, and 34 hours after the 
beginning of fasting); 4) Fasted for 36 hours and injected with leptin (5 mg/kg body weight) 
(Los Angeles Biomedical Research Institute) at 34 hours. The mice were euthanized and the 
hypothalami were dissected. All hypothalami used in the following experiments were 
confirmed for GFP expression under a fluorescent microscope. All animal work was 
approved by the UCSF Institutional Animal Care and Use Committee.
Immunostaining
Mice were anesthetized with pentobarbital (7.5 mg/0.15 ml, i.p.) and transcardially perfused 
with 10ml of heparinized saline (10 U/ml, 2 ml/min) followed by 10ml of phosphate-
buffered 4% paraformaldehyde (PFA). Brains were removed, postfixed for 24 hours in 4% 
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PFA, and then equilibrated in PBS with 30% sucrose for 72 hours. Brains were sectioned 
coronally (35 microns) on a sliding microtome (Leica SM 2000R). Immunohistochemistry 
was performed as previously described 35-37. Coronal brain sections that had been stored in 
PBS at 4°C were permeabilized and blocked with 3% normal goat serum/0.3% Triton X-100 
for 1 hour and then incubated at 4°C overnight with chicken anti-GFP (abcam, ab13970) as 
the primary antibody and goat anti chicken IgY Alexa fluor 488 (Invitrogen, A11039) as the 
secondary antibody at a dilution of 1:500. Sections were placed in 4,6- diamidino-2- 
phenylindole (DAPI) (0.2 g /ml; 236276; Roche) for 10 minutes and then mounted on plus 
coated slides and coverslipped using Vectashield (H-1000; Vector Laboratories). Images 
were captured using a Zeiss Apotome.
RNA-seq
Three biological replicates were done for each condition and five hypothalami were used in 
each replicate. Hypothalami were pooled and homogenized by douncing 30 times in 1 mL 
lysis buffer (15 mM Tris-HCL (pH 7.5), 0.1 mM EGTA, 15 mM NaCl, 60 mM KCl, 5 mM 
MgCl2, 300 mM sucrose, 1 mM DTT, 0.1 mM PMSF, 0.15 mM spermine, 0.5 mM 
spermidine, Complete protease inhibitor (Roche) and 20mM Na-butyrate (Sigma), RiboLock 
RNase inhibitor) using a tissue grinder type B (Kimble Chase). The cell lysate was 
centrifuged at 500 g for 5 minutes at 4ºC. Pellet was re-suspended in 1 mL lysis buffer, and 
equal volume of nuclei isolation buffer (lysis buffer supplemented with NP40 at 0.4%) was 
added. The lysate was incubated on ice for 5 minutes, followed by centrifugation at 7000 g 
for 5 minutes at 4ºC. Cell nuclei pellet was re-suspended in 250 uL FACS buffer (0.15 mM 
spermine, 0.5 mM spermidine, Complete protease inhibitor (Roche) and 20mM Na-butyrate 
(Sigma), RiboLock RNase inhibitor in PBS. FACS was performed with FACS Aria II (BD 
Biosciences) equipped with 70 um nozzle. 50,000–70,000 GFP positive and negative nuclei 
were sorted directly into buffer RLT supplemented with beta-mercaptoethanol. Cell nuclei 
with fluorescence levels 0–600 were defined as GFP negative, and those with ≥6,000 as GFP 
positive (Supplementary Figure 1). RNA was extracted using RNeasy mini kit (Qiagen) 
following the manufacture’s protocol. RNA was quantified with Qubit RNA HS assay kit. 
cDNA was amplified using Ovation V2 kit (NuGEN) and sequencing libraries were 
generated using NexteraXT kit (Illumina). RNA-seq was carried out on an Illumina HiSeq 
4000. Sequence alignment was performed using STAR38. Mappings were restricted to those 
that were uniquely assigned to the mouse genome and unique read alignments were used to 
quantify expression and aggregated on a per-gene basis using the Ensembl (GRCm37.67) 
annotation. We analyzed these raw data using DESeq239 to assess variance and differential 
expression between sample groups. All RNA-seq data was deposited in NCBI as Bioproject 
PRJNA418102. To compare our RNA-seq result to previous work isolating LepRb neurons 
followed by TRAP-seq22, we selected all differentially expressed genes between GFP 
positive and GFP negative conditions. We then further divided those genes into genes more 
highly expressed in GFP positive cells or higher in GFP negative cells. These differentially 
expressed genes where then compared to the TRAP-seq results in LepRb positive or LepRb 
negative cells. Additionally, we carried out gene ontology and pathway enrichment analysis 
on differentially expressed genes using DAVID40 through the DAVIDWebService package41 
on Bioconductor. For unsupervised clustering, we utilized the WGCNA20 package. Genes 
were first filtered to remove those with less than 90% of the samples containing normalized 
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read count depth of 20 (kept 11,125 genes). Module assignment was then inspected after 
carrying out the blockwiseModules function with a parameter sweep for options power 
(values: 6, 7, 8 and 9), minimumModuleSize (values 10, 15, 20, 25, 30, 40 and 50) and 
mergeCutHeight (values .1, .15, .20, .25, .30 and .35). From this power = 7, minModuleSize 
= 50 and k = .15 were determined to give optimal module assignment based on inspection of 
gene dendrograms, the number of total clusters and the number of genes in each cluster. 
From this point, the modules were correlated to the experimental groups following the 
WGCNA vignette and p-values of this correlation were adjusted for multiple testing using 
the False Discovery Rate (FDR). As with the differentially expressed genes, enrichment for 
gene ontology and pathways in each module’s gene set was determined using DAVID40 and 
the DAVID WebService package41.
ChIP-seq
Twenty hypothalami were used for each individual ChIP-seq experiment and two biological 
replicates were done for each condition. Cell nuclei were isolated and pelleted as described 
above. Cell nuclei pellet was re-suspended in 2 mL FACS buffer (0.15 mM spermine, 0.5 
mM spermidine, Complete protease inhibitor (Roche) and 20mM Na-butyrate (Sigma) in 
PBS). FACS was performed with FACS Aria II (BD Biosciences) equipped with 100 um 
nozzle. 300,000–540,000 GFP positive and negative nuclei were sorted into PBS. After 
FACS, FACS buffer was added for a final volume of 10 mL. 50 uL of 1M CaCl2 and 30 uL 
of 1M MgAc2 was added and incubated on ice for 5 minutes, followed by centrifugation at 
1800 g for 15 minutes at 4ºC. The supernatant was removed and FACS buffer supplemented 
with 1% formaldehyde was gently added onto the pellet to crosslink chromatin. The 
crosslinked pellet was then washed with FACS buffer supplemented with 125 mM glycine 
without disturbing the pellet. The crosslinked chromatin was lysed in 130 uL of Buffer B 
(LowCell# ChIP kit, diagenode) supplemented with Complete protease inhibitor (Roche) 
and 20mM Na-butyrate (Sigma). The lysed chromatin was sheared using a Covaris S2 
sonicator to obtain on average 250bp size fragments. 870 uL of Buffer A (LowCell# ChIP 
kit, diagenode) supplemented with complete protease inhibitor (Roche) and 20mM Na-
butyrate (Sigma) was added. 20 uL of the chromatin solution was saved as an input control. 
A mixture of 40 uL of Dynabeads protein A and 40 uL of Dynabeads protein G was washed 
twice with Buffer A (LowCell# ChIP kit, diagenode) and resuspended in 800 uL of Buffer 
A. 10 ug of H3K27ac antibody (ab4729, Abcam) was added to the beads, and gently 
agitated at 4ºC for 2 hours. The beads-antibody complex was precipitated with a magnet, 
and the supernatant was removed. 800 uL of shared chromatin was added to the beads-
antibody complex and rotated at 4ºC overnight. The immobilized chromatin was then 
washed with Buffer A three times and Buffer C once, and eluted in 100 uL of IPure elution 
buffer (IPure kit, diagenode). In addition, 80 uL of IPure elution buffer was added to 20 uL 
input. DNA was purified using the IPure kit according to manufacture’s protocol. 
Sequencing libraries were generated using Accel-NGS 2S Plus DNA library kit (Swift 
Biosciences). DNA was quantified with Qubit DNA HS assay kit and Bioanalyzer (Agilent) 
using the DNA High Sensitivity kit. Massively parallel sequencing was performed on an 
Illumina Hiseq 4000. Sequencing reads were mapped to the genome using bowtie42 allowing 
one mismatch per read-alignment and only uniquely aligned reads (-v 1 -m 1). Peaks were 
called against input using MACS243. Reliable peaks were identified using the ENCODE 
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Irreproducible Discovery Rate (IDR; 44) pipeline, which establishes a p-value cutoff to 
accept peak calls for each condition. For differential peak intensity analysis, peaks across 
conditions were partitioned using BEDTools45 and read coverage obtained using HTSeq46. 
Peaks differentially enriched for H3K27ac histone marks were then identified using 
DESeq239. Differentially enriched peaks were tested for enrichment for novel motifs and 
known transcription factor binding sites with MEME-ChIP28. Test peak regions were split 
into peaks either showing increased enrichment in GFP-positive cells or GFP-negative cells. 
The peaks were then divided into 500bp windows or smaller using BedTools45 
makewindows command. The Fasta sequences for these regions were then extracted using 
BedTools getfasta with the repeat masked version of the Ensembl Mouse genome. MEME-
ChIP was then run on each set of windowed peaks using the following parameters: -db ~/
tools/meme-5.0.0/db/motif_databases/JASPAR/JASPAR2018_CORE_vertebrates_non-
redundant.meme -meme-minw 6 -meme-maxw 12 -meme-nmotifs 500 -meme-minsites 50 -
meme-maxsites 500 -meme-p 12. All ChIP-seq data was deposited in NCBI as Bioproject 
PRJNA418098.
ATAC-seq
Five hypothalami were used for the ATAC-seq using two biological replicates for each 
condition. Cell nuclei were isolated and pelleted as described above. Cell nuclei pellet was 
re-suspended in 250 uL FACS buffer (0.15 mM spermine, 0.5 mM spermidine in PBS). 
FACS was performed with the FACS Aria II (BD Biosciences) equipped with 70 um nozzle. 
GFP positive and negative nuclei were sorted into PBS. After FACS, 49 uL of sorted nuclei 
(11,200–18,000 nuclei) were mixed with 50 uL Tagment DNA buffer (Nextera DNA sample 
preparation kit, Illumina) and 1 uL of Tagment DNA enzyme (Nextera DNA sample 
preparation kit, Illumina), followed by incubation at 37ºC for 30 minutes. Tagmented DNA 
was purified with MinElute reaction cleanup kit (Qiagen). The DNA was size-selected using 
SPRIselect (Beckman Coulter) according to manufacture’s double size selection protocol. 
DNA:SPRIselect ratio was 5:3 for right side, and 2:3 for left side selection. Library 
amplification was performed as described previously47. Amplified library was further 
purified with SPRIselect as described above. DNA was quantified using the Qubit DNA HS 
assay kit and Bioanalyzer (Agilent) using the DNA High Sensitivity kit. Massively parallel 
sequencing was performed on an Illumina Hiseq 4000. Sequencing reads were mapped to 
the genome using Bowtie248; options: --no-unal -X 2000 --no-discordant --no-mixed --local 
--very-sensitive-local). After duplicate read removal, samples were merged into a GFP 
positive and GFP negative pool for peak calling with MACS243 and reliable peaks were 
identified using the ENCODE IDR44 pipeline. As with ChIP-seq, peaks were then 
partitioned with BEDTools45, read coverage obtained using HTSeq46 and differentially 
enriched peaks identified using DESeq239. Differentially enriched ATAC-seq peaks were 
tested for enrichment for novel motifs and known transcription factor binding sites with 
MEME-ChIP28 in a similar fashion as the ChIP-seq peaks above. However, due to peak 
regions being generally smaller, peaks were divided into 200bp windows or smaller using 
BedTools45 makewindows command. All ATAC-seq data was deposited in NCBI as 
Bioproject PRJNA418098.
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GWAS and GTEX analyses
Obesity-associated variants were obtained from Ghosh and Bouchard, Nature Reviews 
Genetics, 201712. Variants in high linkage disequilibrium (r2 of at least 0.8) with obesity-
associated SNPs were then obtained the 1000 Genomes data49 in all five available 
populations (AMR, AFR,EUR, EAS, SAS) with Plink31. All lead and linkage variants from 
all five populations were then concatenated into a single list with their locations in the 
human hg19 assembly. The coordinates of these variants were then intersected with the 
ChIP-seq and ATAC-seq peaks after using the UCSC LiftOver tool using BEDTools45. We 
used a random permutation test to determine the statistical significance of the rate of 
intersection. To do this, we randomly shuffled lifted over mouse peaks using BEDTools45, 
after excluding regions on the ENCODE32 blacklist, a total of 10,000 times. For each 
shuffle, we recorded the number of peaks that contained an obesity-associated lead or linked 
variants. We then compared the observed occurrences in the ChIP-seq or ATAC-seq data to 
the random permutations. The raw p-value was determined to be equal to the number of 
permutations greater than the observed plus one, divided by the total number of 
permutations plus one. Raw p-values were adjusted for multiple testing using FDR methods 
and the R p.adjust function. Hypothalamus eQTL variants were downloaded from the 
GTEX50 portal (https://gtexportal.org/home/datasets). Similar to the obesity-associated 
variants identified through GWAS studies, we intersected these variants on the human 
genome with the lifted over ChIP-seq and ATAC-seq peak regions and carried out a random 
permutation test with a total of 1,000 permutations (fewer permutations were carried out due 
to the lower degree of significance identified). Raw p-values and FDR adjusted p-values 
were obtained as described above.
Luciferase assays
The three genomic regions around Socs3 (Socs3–1, Socs3–2, and Socs3–3) were amplified 
via PCR from the mouse genome using specific primers (Supplementary Table 4), and 
cloned into the pGL4.23 (Promega) enhancer assay vector using In-Fusion HD cloning kit 
(Takara) following the manufacturer’s protocol. For luciferase assays, mHypoA-POMC/
GFP-1 cells were seeded in 96-well plate with 1×104 cells/well at 24 hours before 
transfection. 120 ng of plasmid per well were transfected along with 30 ng of pGL4.74 
Renilla luciferase expression vector (Promega), to correct for transfection efficiency, using 
XtremeGENE HP DNA transfection reagent (Roche). DNA:XtremeGENE ratio was 1:2. 
Firefly and Renilla luciferase activities were measured 24 hours after transfection using the 
Dual-luciferase reporter assay system (Promega) on a Synergy2 (Biotek) following the 
manufacturer’s protocol.
CRISPRi
sgRNA sequences (Supplementary Table 4) were cloned into the pLG1 plasmid (gift from 
Prof. Jonathan Weissman). Intact pLG1 plasmid that contains sgRNA sequence against 
EGFP gene was also used as a negative control. sgRNA containing pLG1 vectors along with 
the pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene, plasmid #60954) were used to 
generate lentivirus using the Lenti-Pac HIV expression packaging kit (GeneCopoeia). 
Lentivirus was concentrated using the Lenti-X Concentrator (Takara). mHypoA-POMC/
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GFP-1 cells were infected with sgRNA and KRAB-dCas9 virus (1:1 ratio) at a multiplicity 
of infection (MOI) of 0.5. Following 48 hours, RNA was extracted using the RNeasy mini 
kit (Qiagen) and reverse-transcribed using Superscript III reverse transcriptase (Invitrogen). 
Gene expression was examined by RT-qPCR using SSO fast EvaGreen supermix (Bio-Rad) 
was carried out on an Eppendorf Realplex 2. Primers used for the qPCR are shown in 
Supplementary Table 4.
Reporting Summary
Further information on research design is available in the Nature Research Reporting 
Summary linked to this article.
Data availability
RNA-seq data are available in Bioproject: PRJNA418102. ChIP-seq and ATAC-seq are 
available in Bioproject: PRJNA418098. The data that support the findings of this study are 
available from the corresponding author upon request.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Isolation of LepRb GFP-positive nuclei. a R26-CAG-LSL-Sun1-sfGFP-myc homozygous 
mice were crossed with LepRbcre mice to obtain mice that express sfGFP in LepRb 
expressing cell nuclei. b Immunostaining showing sfGFP expression in the dorsomedial 
hypothalamus (DMH), ventromedial hypothalamus (VMH) and arcuate nucleus (ARC). On 
the right panel is a zoom in on the ARC along with DAPI staining (blue). c FACS histogram 
showing clear separation of GFP-positive from GFP-negative nuclei obtained from LepRbcre 
X R26-CAG-LSL-Sun1-sfGFP-myc heterozygous mice. Similar results were obtained in all 
the experimental groups (Supplementary Figure 1). d LepRbcre X R26-CAG-LSL-Sun1-
sfGFP-myc heterozygous mice were fed or fasted for 36 hours, during which saline (blue) or 
leptin (orange) were injected at various time points. Cell nuclei were isolated and sorted via 
FACS, followed by RNA-seq, ChIP-seq, and ATAC-seq.
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Fig 2. 
LepRb-GFP positive nuclei transcriptome. a Comparison of normalized counts for Lepr and 
genes specific for neurons (Elavl4(HUD), microglia (Cx3cr1), oligodendrocytes (Mag) and 
astrocytes (Adh1l1) in transcriptomes from GFP positive and GFP negative nuclei. Box plots 
represent the 25th to 75th percentiles and the midline indicates the median. Each point 
represents data from five pooled hypothalamus. b Volcano plot showing all differentially 
expressed genes when comparing LepRb GFP positive to GFP negative nuclei. c Volcano 
plot showing all differentially expressed lncRNAs when comparing LepRb GFP positive to 
GFP negative nuclei. Selected genes and lncRNAs are labeled. n=12 biologically 
independent replicates while pooling all physiological conditions tested (a-c). P-values given 
from Wald test and correct for multiple testing using the Benjamini & Hochberg procedure 
(FDR; b and c).
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Fig. 3. 
Leptin-responsive transcriptome. a A heatmap of mean subtracted, log stabilized read counts 
showing differentially expressed genes for fasted mice treated either with saline (SSS) or 
with leptin at 12, 24 and 34 hours (LLL). b Boxplots showing the expression levels of Etv6, 
Socs3 and Gucy2c in LepRb GFP-positive (green) or negative (grey) nuclei within the two 
conditions. The y-axis shows stabilized expression which is log2 scale for sequencing depth 
normalized counts determined by DESeq239. Box plots represent 25th to 75th percentiles 
and the midline indicates the median. n=3 biologically independent replicates.
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Fig. 4. 
LepRb-GFP positive regulome. a-b Genomic snapshots of Lepr (a) and Sim1 (b) loci 
showing enrichment of H3K27ac ChIP-seq and ATAC-seq signals around Lepr in Leptin-
responsive neurons (green) compared to GFP-negative nuclei (grey) and the opposite for 
Sim1. Leptin conditions include mice treated with saline (SSS) or leptin (LLL) injections at 
12, 24 and 34 hours (LLL) or saline injections at 12 and 24 hours followed by a single leptin 
injection at 34 hours (SSL). The obesity SNPs track for Lepr shows obesity-associated 
SNPs33, including SNPs that are in linkage disequilibrium (r2>0.8) with the lead SNP 
rs11804091 (red line). Each of the two replicates for ChIP-seq and ATAC-seq presented 
comparable signals as shown. c-d Heatmaps showing differential ChIP-seq (c) and ATAC-
seq (d) peaks between leptin-responsive and GFP negative nuclei. Two replicates are shown 
for each condition. e GREAT analysis27 for H3K27ac ChIP-seq peaks that are enriched in 
LepRb GFP-positive nuclei (n=7,726; p-values obtained by binomial enrichment test).
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Fig. 5. 
Functional characterization of a Socs3 enhancer. a A genomic snapshot of the Socs3 locus 
showing three candidate enhancer sequences, Socs3-1 (1), Socs3-2 (2), and Socs3-3 (3), that 
are enriched for H3K27ac ChIP-seq and ATAC-seq signals in LepRb GFP-positive nuclei 
(green) compared to GFP-negative nuclei (grey). Each of the two replicates for ChIP-seq and 
ATAC-seq presented comparable signals as shown. b Luciferase assay for all three candidate 
enhancer sequences (Socs3-1, Socs3-2, and Socs3-3). Fold activity is compared to the empty 
vector (pGL4.23) and data are presented as means ± the lower and upper quartile and lines 
represent the minimum and maximum from three independent biological experiments. c-e 
CRISPRi targeting of Soc3-3. Two sgRNAs (Socs3_sgRNA_1 and Socs3_sgRNA_2) that 
target the Socs3-3 enhancer along with dCas9-KRAB show significantly reduced expression 
of Socs3 via RT-qPCR when compared both to a negative control sgRNA (NC-sgRNA) or 
no infection control (no-sgRNA). The neighboring genes, Pgs1 (d) and Tha1 (e), do not 
show any significant changes in gene expression. Boxes represent 25th to 75th percentiles 
and the midline indicates the median. n=3 biologically independent replicates. Two-sided 
student’s t-test was used to determine statistical significance (**p<0.01. *p<0.05).
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Fig. 6. 
Obesity GWAS loci. a tSNE plot showing the differences in obesity-associated SNP-
overlaps between tissue and data types. The tSNE plot was generated from a matrix of 
obesity-associated SNPs which overlap each ChIP-seq or ATAC-seq dataset, such that rows 
were SNPs and columns samples. Each field was assigned either a 0 (no overlap) or 1 
(obesity-associated SNP was overlapped). Color represents the data type: Red – ATAC-seq, 
Blue – ChIP-seq. The darkness of the color represents the total number of obesity-associated 
SNPs that overlapped each dataset. b-c Genomic snapshots of Sec16b (b) and Tnni3k (c) 
loci showing H3K27ac ChIP-seq and ATAC-seq signals in leptin-responsive neurons (green) 
compared to GFP-negative nuclei (grey). Leptin conditions include mice treated with saline 
(SSS) or leptin (LLL) injections at 12, 24 and 34 hours (LLL) or saline injections at 12 and 
24 hours followed by a single leptin injection at 34 hours (SSL). The obesity SNPs track 
shows the obesity-associated lead SNP a as red line and in addition SNPs that are in linkage 
disequilibrium (r2>0.8) as black lines. Each of the two replicates for ChIP-seq and ATAC-
seq presented comparable signals as shown.
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